Accueil・Liste d'Actions・Avita Therapeutics Inc

Avita Therapeutics Inc

Fermé

13.06 -0.46

Acheter Vendre

Résumé

Variation du prix de l'action

24h

Actuel

Min

13.04

Max

13.22

Chiffres clés
By Trading Economics
Revenu	2.9M -7.7M
Ventes	2.5M 22M
BPA	-0.25
Marge bénéficiaire	-35.31
Employés	226
EBITDA	3.8M -4.8M

Recommandations
By TipRanks
Recommandations	Achat Fort
Prévisions sur 12 Mois	-6.64% downside

Dividendes
By Acuity
Prochains Résultats	5 nov. 2026

Statistiques du Marché
By TradingEconomics
Capitalisation Boursière	268M 410M
Ouverture précédente	13.52
Clôture précédente	13.06

Avita Therapeutics Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

10 oct. 2026, 23:51 UTC

Canada's Housing Starts Data Set for Release Amidst Weak Employment Figures, Forecasting 230K Units and Cautious Market Sentiment.

10 oct. 2026, 23:41 UTC

Market Awaits NY Empire State Manufacturing Index Release Amid Cautious Optimism and Broader Economic Concerns on October 15, 2026.

10 oct. 2026, 23:41 UTC

Philadelphia Fed Manufacturing Index for October 2026 set to release with optimistic growth forecast amid inflation concerns and upcoming earnings reports.

10 oct. 2026, 23:41 UTC

Core Producer Prices Expected to Rise 0.3% in September, Amid Cautious Market Sentiment and Inflation Concerns Ahead of Key Economic Reports

10 oct. 2026, 23:41 UTC

US Producer Price Index Expected to Rise 0.5% Amidst Deteriorating Consumer Confidence and Inflation Concerns Ahead of October Release

10 oct. 2026, 23:31 UTC

Australia's upcoming employment data release on October 15 is crucial, following a significant decline in full-time jobs and amid cautious economic sentiment influenced by global market fluctuations.

10 oct. 2026, 23:31 UTC

Australia's Unemployment Rate Expected to Rise to 4.6% in September, Sparking Concerns Over Labor Market Stability Amid Global Economic Volatility

10 oct. 2026, 23:31 UTC

Australia's Employment Change Report on October 15 Expected to Show Job Growth Amid Global Labor Market Concerns.

10 oct. 2026, 23:21 UTC

US CPI Release on October 14 Sparks Caution Among Investors Amid Declining Consumer Sentiment and Inflation Concerns

10 oct. 2026, 23:21 UTC

U.S. CPI data release on October 14 expected to show inflation rise to 3.6%, amid declining consumer confidence and fears of Federal Reserve tightening ahead of midterm elections.

10 oct. 2026, 23:21 UTC

Core Inflation Rate Release on October 14, 2026, Expected to Rise by 0.2%, Influencing Federal Reserve Interest Rate Decisions Amidst Cautious Market Sentiment and Consumer Concerns Over Rising Costs.

10 oct. 2026, 23:21 UTC

U.S. Inflation Rate Expected to Rise 0.6% in September Amid Consumer Confidence Decline and Geopolitical Tensions, Influencing Federal Reserve Policy Discussions

10 oct. 2026, 23:21 UTC

Market Anticipates CPI Release Amid Rising Inflation Concerns and Mixed Investor Sentiment

10 oct. 2026, 23:21 UTC

Core Inflation Rate for September 2026 Expected to Rise Slightly to 2.5%, Heightening Market Caution Amidst Rising Consumer Sentiment and Geopolitical Tensions.

10 oct. 2026, 23:11 UTC

Brazil's Retail Sales Data Release on October 15 Expected to Reveal Consumer Spending Trends Amid Cautious Market Sentiment.

10 oct. 2026, 23:01 UTC

Macro News

The Dow Jones Index (US) is trading roughly flat in after-market hours amid concerns over semiconductor stocks and heightened geopolitical tensions.

10 oct. 2026, 22:51 UTC

Japan's Machinery Orders MoM data for August, set to release on October 14, is expected to show a modest 2.5% growth amid mixed manufacturing sentiment and concerns over softening demand.

10 oct. 2026, 22:51 UTC

Australia's NAB Business Confidence report set for October 13 reveals cautious market sentiment amid declining confidence and rising costs, raising concerns over economic stability.

10 oct. 2026, 22:51 UTC

RBA Meeting Minutes on October 13, 2026, Expected to Influence Interest Rate Decisions Amid Inflation Concerns and Global Economic Factors.

10 oct. 2026, 22:51 UTC

The Nikkei 225 Index is roughly flat in after-market trading, holding steady since Friday's close amid positive sentiment ahead of upcoming corporate earnings reports.

10 oct. 2026, 22:41 UTC

Singapore's Q3 2026 GDP Growth Rate Release on October 14 Sparks Cautious Optimism Amid Economic Recovery Signs and Mixed Asian Market Sentiments.

10 oct. 2026, 22:41 UTC

U.S. 30-Year Mortgage Rates Hit 7.49% Amid Rising Treasury Yields and Inflation Concerns, Forecasting Continued Upward Pressure on Housing Market Demand

10 oct. 2026, 22:31 UTC

Brazil's Central Bank to Release Key Interest Rate Insights Amid Rising Inflation on October 13, 2026.

10 oct. 2026, 22:21 UTC

South Korea's Unemployment Rate Release on October 15 Expected to Reflect Labor Market Resilience Amid Global Economic Pressures.

10 oct. 2026, 22:01 UTC

Spain's Consumer Confidence Index set for October 13 release amid cautious sentiment due to inflation and geopolitical tensions.

10 oct. 2026, 21:31 UTC

Italy's Balance of Trade data set for October 16, with a forecasted €7.5 billion surplus amid cautious sentiment following disappointing industrial production figures.

10 oct. 2026, 21:31 UTC

UK Retail Sales Monitor YoY for September 2026 Expected to Show Modest 0.7% Increase Amid Cautious Consumer Sentiment and Inflation Concerns

10 oct. 2026, 20:41 UTC

India's Inflation Rate YoY Release on October 12, 2026, Expected to Reflect Ongoing Energy Price Pressures Amid Optimistic Market Sentiment.

10 oct. 2026, 20:31 UTC

API Crude Oil Stock Change Report on October 14, 2026, to Reflect Inventory Fluctuations Amid Geopolitical Tensions and Market Caution Ahead of Key Inflation Data.

10 oct. 2026, 20:31 UTC

Fed Governor Barkin's Upcoming Speech Sparks Cautious Market Sentiment Amid Inflation Concerns and Key Economic Data Releases.

Comparaison

Variation de prix

Avita Therapeutics Inc prévision

Objectif de Prix

By TipRanks

-6.64% baisse

Prévisions sur 12 Mois

Moyen 12.333 USD -6.64%

Haut 14 USD

Bas 11 USD

Basé sur 3 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

3 ratings

Achat

Maintien

Vente

Basé sur 3 qui ont noté l'action Microsoft Corp. au cours des 3 derniers mois.

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

À Propos Avita Therapeutics Inc

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.